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Edited by Horst FeldmannAbstract Synaptic plasticity is a phenomenon contributing to
changes in the eﬃcacy of neuronal transmission. These changes
are widely believed to be a major cellular basis for learning and
memory. Protein phosphorylation is a key biochemical process
involved in synaptic plasticity that operates through a tight
balance between the action of protein kinases and protein
phosphatases (PPs). Although the majority of research in this
ﬁeld has concentrated primarily on protein kinases, the signiﬁcant
role of PPs is becoming increasingly apparent. This review
examines one such phosphatase, PP1, and highlights recent
advances in the understanding of its intervention in synaptic and
structural plasticity and the mechanisms of learning and memory.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Protein phosphorylation is one of the most important and
widespread post-translational modiﬁcations in cells that drives
rapid, reversible and activity-dependent signal transduction.
The process of phosphorylation can lead to the activation of
various types of targets, including membrane receptors, in-
tracellular enzymes, or cytoskeletal proteins, and can regulate
processes such as protein traﬃcking, protein–protein interac-
tions, enzyme activity as well as a multitude of cellular pro-
cesses from apoptosis to synaptogenesis. The role of protein
phosphatases (PPs) in biological systems is often considered* Corresponding author. Fax: +41-1-633-10-69.
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are the primary eﬀectors of phosphorylation while phospha-
tases are the eﬀectors of dephosphorylation. However, protein
phosphorylation/dephosphorylation is a dynamic process that
relies equally on protein kinases and PPs and more speciﬁcally,
on a delicate and concerted balance between these proteins.
Four major PPs, able to speciﬁcally remove phosphate
groups from serine (Ser) and threonine (Thr) residues, are
present in the cytoplasm of animal cells [1]. PP1, PP2A, and
PP2B are three of these enzymes encoded by the same gene
family while PP2C arises from a distinct gene. PP1, PP2A, and
PP2B are complexed to other proteins in vivo and have broad
and overlapping speciﬁcities in vitro accounting for virtually
all measurable Ser/Thr phosphatase activity in tissue extracts.
PPs are highly abundant in the brain where, together with
protein kinases, they contribute to the control of synaptic
plasticity and memory. Synaptic plasticity is a property of
neuronal connections, or synapses, which modiﬁes the eﬃcacy
of synaptic transmission. Such modulation of transmission
eﬃcacy is driven by correlations in the ﬁring activity of pre-
and postsynaptic neurons, a concept ﬁrst proposed by Donald
Hebb [2]. Strengthening or weakening of synaptic eﬃcacy is
believed to be a cellular basis for learning and memory. Re-
search in the last decade has implicated many protein kinases
in short- and long-term modiﬁcation of signal transmission
between synapses, but recently the functional role of comple-
mentary PPs has also been revealed.
This review covers recent advances on PP1 and its involve-
ment in protein phosphorylation in synaptic and structural
plasticity, and ultimately in learning and memory. Recent data
from a variety of studies utilizing pharmacological, behavio-
ural, imaging and electrophysiological techniques suggest that
PP1 not only functions to reverse kinase activity but to nega-
tively regulate synaptic strength, and learning and memory.2. PP1
The role of PP1 was initially described after discovery of its
participation in the regulation of glycogen metabolism, but it
was subsequently discovered to have an essential role in many
other cellular processes such as cell division, muscle contrac-
tility, transcription, translation and apoptosis. The importance
of PP1 in neural systems became was apparent after the dis-
covery of high expression of several of its catalytic subunits in
brain tissue, including a, b, c1, and c2. Multiple interactionsation of European Biochemical Societies.
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eral isoforms to varying but distinct subcellular locations. For
example, the b isoform is found predominantly in the cell
soma, whereas c1 in addition to the soma is also found in large
quantities in dendrites and presynaptic boutons where it co-
localizes with abundant neuronal proteins such as calcium/
calmodulin-dependent protein kinase type II (CaMKII) and
synaptophysin [3].3. Endogenous regulation of PP1 activity
The speciﬁcity and activity of PP1 is largely controlled by
interacting proteins, the majority of which act as regulatory
subunits modulating PP1 catalytic activity, or scaﬀolding
proteins that compartmentalize PP1 to discrete subcellular
locations in close proximity to target substrates. Many en-
dogenous proteins have been shown to interact with PP1,
leading to substantial changes in localization and activity
(Table 1). Most of these interacting protein sequences include
two highly conserved docking motifs, [RK]-x(0,1)-V-x-F and
F-x-x-[RK]-x-[RK], expressed in standard ProSite format.
Most regulatory accessory proteins have inhibitory actions on
PP1 activity. An additional level of regulation occurs via
phosphorylation of these inhibitory proteins. For example,
inhibitor 1 (I1) is an ubiquitously expressed 28 kDa protein
which upon phosphorylation by cAMP-dependent protein
kinase A (PKA), results in potent inhibition of PP1. I1 mes-
senger RNA (mRNA) is strongly expressed in the hippo-
campus [4] and I1 protein is found in the CA1 region of the
hippocampus [5]. Other proteins such as G-substrate and
dopamine and cAMP-regulated phosphoprotein Mr 32000
(DARPP-32), which exhibit considerable sequence overlap
with I1, also inhibit PP1 [6]. Although the most thoroughly
researched accessory proteins are inhibitory, two proteins
which inhibit the related phosphatase PP2A, I1 (PP2A) and I2
(PP2A), actually increase the catalytic activity of PP1 in vitro
[7]. In neural tissue, the sequestration of PP1 to structures
such as the postsynaptic density (PSD), a multi-protein
complex found at synapses and that contains hundreds of
signal transduction molecules, is particularly important forTable 1
Proteins interacting with PP1
Protein Location
Inhibitors
I1 Widely distributed, cytosol
DARPP-32 Brain, kidney, cytosol








Neurabin I Neuronal, plasma membrane and actin
Spinophilin (neurabin II) Plasma membrane and actin cytoskelet
NF-L (neuroﬁlament-L) Neuronal, plasma membrane and cytos
AKAP220 Brain, testis, peroxisomes/cytoskeleton
Yotiao (AKAP) NMDA receptor
BH-protocadherin Neuronal membrane
Tau Neuronal microtubules
Neuronal proteins interacting with PP1. The majority of PP1 interacting prote
on binding motifs and a list of published interacting partners of PP1 can bethe functioning of many signalling proteins. Yotiao is a neu-
romuscular junction protein member of the A-kinase an-
choring protein (AKAP) family that sequesters both PKA and
PP1 to N-methyl-D-aspartate (NMDA) type glutamate re-
ceptors [19]. Spinophilin is a binding protein containing a
postsynaptic-density-protein/disc-large/zo-1 (PDZ) domain,
sequestering PP1 to actin. Spinophilin is also responsible for
the association of PP1 with other receptors such as the D2
dopamine (DA) receptor [20], alpha adrenergic receptor [21]
and p70S6 kinase (p70S6K) [22]. The role of a selection of
PP1 interacting proteins in synaptic activity is explored in the
following sections.4. Modulation of glutamatergic transmission
Synaptic transmission involves the release of a neuro-
transmitter from a presynaptic neuron and activation of sig-
nalling cascades via receptors on the postsynaptic membrane
of another neuron. The nature and magnitude of the post-
synaptic signal can be modulated by the actions of protein
kinases and PPs, which often work via complex feedback
loops and cross-talk between diﬀerent signalling cascades re-
sulting in tight control over communication between neurons.
Changes in synaptic transmission can involve protein tran-
scription and protein synthesis DNA translation although the
following sections illustrate the importance of PP1 in modu-
lation of glutamatergic activity at synapses. Glutamate is the
major excitatory neurotransmitter in mammalian nervous
system that mediates its eﬀects in part through a-amino-3-
hydroxy-5-methyl-4-isoxazole proprionic acid (AMPA) and
NMDA receptors. Both AMPA and NMDA receptors are
members of ionotropic receptor superfamily, and upon
binding of glutamate, allow entry of cations into the neuron.
In neostriatal neurons AMPA receptor activity was shown to
be regulated by PP1 by two distinct molecular mechanisms
[23]. Firstly, control of AMPA receptor activity is regulated
by the association of PP1 to spinophilin localizing PP1 to the
PSD and in close proximity to AMPA receptors. Secondly,
phosphorylated DARPP-32, a DA- and cAMP-regulated
phosphoprotein highly enriched in the neostriatum, inhibitsFunction Reference
Inhibition of PP1 [8]
Inhibition of PP1 [9]
Inhibition of PP1 [10]
Inhibition of PP1 [11]
Inhibition of PP2A but stimulation
of PP1
[7]
cytoskeleton Neurite outgrowth [12]
on Glutamatergic transmission [13]
keleton Synaptic transmission? [14]
PKA and PP1 signalling [15]
Synaptic transmission [16]
Neuronal cell–cell interactions [17]
Microtubule stability [18]
ins are inhibitory and scaﬀolding proteins. Comprehensive information
found at http://pp1signature.pasteur.fr/.
R.P. Munton et al. / FEBS Letters 567 (2004) 121–128 123PP1 and thus maintains AMPA receptor currents. Accord-
ingly, intracellular application of dephosphorylated DARPP-
32 rapidly reduced AMPA receptor currents. Phosphorylation
of DARPP-32 occurs after activation of PKA by stimulation
of dopamine-D1 receptors, suggesting that PP1 is heavily
involved in the interplay and cross-talk between multiple
signalling cascades. DARPP-32 is also involved in PP1 regu-
lation of NMDA receptor responses providing further evi-
dence for cross-talk between glutamatergic and dopaminergic
signalling pathways. NMDA receptor currents are known to
be enhanced by phosphorylation as phosphatase inhibitors
enhance NMDA receptor channel currents. Furthermore,
dephosphorylation of NMDA receptors by PP1 and PP2A
has been shown to decrease the probability of channel
opening. DA, via activation of D1 receptors, enhances
NMDA-evoked responses in striatal neurons via PKA phos-
phorylation of DARP-32 [24]. Mice lacking DARPP-32 ex-
hibit reduced enhancement of NMDA receptor currents and,
furthermore, pharmacological inhibition of PP1 by okadaic
acid increased D1-induced NMDA receptor currents. These
data suggest that constitutively active PP1 is responsible for
attenuating NMDA receptor currents.
Another protein that interacts with PP1 could play an im-
portant role in the phosphorylation state of and therefore
functioning of NMDA receptors [16]. The scaﬀolding protein
yotiao binds both the regulatory subunit of PKA and PP1,
sequestering the two enzymes directly to the C-terminus of the
NMDA NR1 subunit. PP1 was found to be constitutively
active and was able to limit NMDA currents when complexed
with yotiao. This process is reversed by PKA-activation, which
rapidly increased channel currents. The ability of yotiao to
sequester a complimentary phosphatase and kinase could be a
way to improve the speed and eﬃciency of activity-dependent
modiﬁcations of the NMDA receptor.Fig. 1. PP1 activity on GluR1 subunit of AMPA receptors plays a pivotal role
PKA-dependent phosphorylation of I1 and subsequent inactivation of PP1.
LTD. Additionally, HFS activates CaMKII which phosphorylates Ser-831 l
cineurin cascade that leads to I1 dephosphorylation and relief of PP1 inhib
LTD. LFS given to a previously potentiated synapse (depotentiation) initiate
synapses (de-depression) phosphorylates Ser-845 by overcoming phosphatas5. Targets of PP1 in long-term potentiation (LTP) and
long-term depression (LTD)
PP1 has also been implicated in long-term changes in
glutamatergic transmission, which is explored in this section
and summarized in Fig. 1. Bidirectional changes in the excit-
ability of neurons are thought to be a major correlate for the
strengthening and weakening of synapses, or synaptic plastic-
ity. Although many types of synaptic plasticity have been de-
scribed, typically changes in synaptic eﬃcacy are a result of
NMDA receptor activation followed by calcium entry, and
activation of kinases and phosphatases (see [25] for review).
PKA, protein kinase C (PKC), and CaMKII have all been
shown to be involved in synaptic plasticity by modulating
glutamate receptor function by phosphorylation of AMPA or
NMDA receptor subunits [26]. LTP is a form of synaptic
plasticity where synaptic eﬃcacy is increased after high fre-
quency stimulation. This stimulation induces transient NMDA
receptor mediated calcium entry resulting in a sustained in-
crease in CaMKII activation due to Thr-286 autophosphory-
lation. It occurs after transient calcium entry induced by
stimulation of NMDA glutamate receptors followed by acti-
vation and persistent increase in CaMKII activity by auto-
phosphorylation at Thr-286. The converse of LTP, LTD, is a
decrease in synaptic eﬃcacy induced by low frequency stimu-
lation, initiated by cascades involving PP1 and calcineurin
(PP2B). The loci of expression of LTP and LTD have not been
determined precisely, but there is ample evidence for the in-
volvement of a multitude of pre- and postsynaptic elements.
For instance, LTP at the Schaﬀer collateral-CA1 synapse in
the hippocampus involves interacting signalling components,
including CaMKII and cAMP pathways (Fig. 1). The in-
volvement of PP1 in CaMKII signalling is tightly regulated
and involves phosphorylation of the inhibitory PP1-interactingin bidirectional synaptic plasticity. High frequency stimulation leads to
This reduces the amount of Ser-845 dephosphorylation, then in turn
eading to LTP. Conversely, low frequency stimulation activates a cal-
ition. PP1 then dephosphorylates Ser-845 leading to the expression of
s dephosphorylation of Ser-831. HFS delivered to previously depressed
e activity.
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cAMP-dependent phosphorylation of endogenous I1 resulting
in a decreased PP1 activity. This same stimulation also results
in increased phosphorylation of CaMKII at Thr-286, indicat-
ing that the cAMP pathway uses PP1 to gate CaMKII sig-
nalling in LTP [5]. Additionally, dephosphorylation of
CaMKII occurs speciﬁcally by the PP1 held in PSD by scaf-
folding proteins [13,27–31], although another phosphatase,
PP2A, which dephosphorylates soluble cytoplasmic CaMKII
is unable to dephosphorylate PSD bound CaMKII [32]. To-
gether, these data illustrate the complexity of the mechanisms
of control of CaMKII activation and in turn of LTP by PP1.
Three decades of research have implicated a multitude of
mechanisms in the induction of LTP and LTD, and a large
body of evidence suggests that both LTP and LTD are asso-
ciated with a change in the phosphorylation state of the GluR1
receptor subunit of AMPA receptor channels. GluR1 receptor
channels can be phosphorylated at two positions, Ser-831 and
Ser-845. Basal phosphorylation of Ser-845 by PKA enhances
GluR1 receptor currents [33], and during LTP, CaMKII
phosphorylates GluR1 subunits at Ser-831 which leads to in-
creased channel conductance in some, but not all neurons.
During LTD, calcineurin activation following low frequency
stimulation dephosphorylates I1, preventing PP1 inhibition,
which in turn dephosphorylates AMPA receptors at Ser-845
decreasing AMPA receptor currents. Additionally, both PP1
and calcineurin have been implicated in activity-dependent
endocytotic internalization of AMPA receptors, an additional
process thought to decrease the eﬃcacy of glutamatergic
transmission during LTD, with dephosphorylation of Ser-845
a pre-requisite for endocytosis [34–36]. Electrophysiological
studies demonstrate that disruption of PP1 binding to synaptic
targeting proteins blocks the induction of LTD by low fre-
quency stimulation, but has no eﬀect on basal synaptic cur-
rents mediated by AMPA or NMDA receptors [37]. Directly
loading PP1 into neurons also had no eﬀect on basal trans-
mission but enhanced the expression of LTD. Additionally,
synaptic activation of NMDA receptors leads to increased PP1
activity at synaptic locations. These results demonstrate that
PP1 does not regulate basal transmission but is involved in
activity-dependent regulation of LTD.
Another type of synaptic depression, depotentiation, has
been described in the hippocampus and also involves PP1.
Depotentiation is the reversal of LTP, reﬂecting a reduction of
the potentiated state of synapses to basal levels, and is a po-
tential mechanism for preventing the saturation of the storage
capacity of a neuronal network [38]. Speciﬁc electrophysio-
logical protocols utilize low frequency stimulation following
LTP, which activates NMDA receptors and phosphatase cas-
cades resulting in dephosphorylation of Ser-residues on GluR1
subunits. Pharmacological agents inhibiting PP1, but not other
phosphatases such as PP2A or calcineurin have been shown to
speciﬁcally prevent depotentiation. In agreement with previous
studies that implicate phosphorylation of Ser-831 by CaMKII
in the induction of LTP, a decrease in phosphorylation at this
site has been observed along with a reduction in Thr-286
phosphorylation of CaMKII. However, Jouvenceau and col-
leagues [39] concluded that LTD and depotentiation are indeed
separate processes involving diﬀerent phosphatase cascades
demonstrating that depotentiation requires PP1, PP2A and
calcineurin, but LTD only requires PP1 and PP2A. Although,
further research is required to delineate the exact functions ofdiﬀerent phosphatases in depotentiation, it is clear that de-
phosphorylation of AMPA receptors by PP1 in depotentiation
is an activity-dependent mechanism.
To summarize, a large body of research has indicated that
PP1 plays an important role in the modulation of synaptic
activity and particularly in the regulation of glutamate recep-
tors in bidirectional plasticity. Such function occurs via a
multitude of mechanisms, involving multiple kinase and
phosphatase cascades. The role of phosphorylation on the
modulation of neuronal activity is activity-dependent and re-
versible, which further illustrates that phosphatase mecha-
nisms not only serve to limit kinase activity in complex
signalling pathways but have their own functions.6. Structural plasticity
6.1. Structural plasticity at the synapse: historical aspects
Besides controlling the above-mentioned molecular events of
synaptic transmission, PP1 is also involved in regulatory
pathways responsible for establishing the structural basis for
long-term memory. Though it is widely accepted that learning
induces not only molecular alterations but also structural
changes, the nature and degree of these changes are not well
known. Even then, it is recognized that the primary substrates
of structural plasticity are dendritic spines, neuronal structures
which hold most synapses in the brain. Spines were described
more than a century ago as small protrusions at the dendritic
surface [40]. These micrometer-sized structures are specialized
for receiving synaptic aﬀerents and accordingly, they cover the
dendrites of many neurons at a high density. Major advances
in understanding the signiﬁcance of dendritic spines are linked
to the development of techniques allowing visualization of
these tiny structures. The ﬁrst method for rendering spines
visible was the silver impregnation technique introduced by
Camillo Golgi. Spines revealed by Golgi staining have imme-
diately captivated neuroscientists and gained a pivotal role in
theories of neural function. As early as 1899, Ramon y Cajal
postulated that spines are motile structures that can have a role
in the regulation of neuronal activity. It took more than half a
century to prove unambiguously with electron microscopy
(EM) analysis that spines indeed bear synapses and therefore
are directly involved in neuronal communication. At that time,
however, dendritic protrusions were generally considered as
immobile elements of the ‘‘hardwired’’ brain with little ca-
pacity for plasticity. Intriguingly, the pioneering studies which
mobilized the ﬁeld presented only indirect clues for spine
motility by detecting actin in dendritic spines [41]. Several lines
of neurobiology research have now provided direct evidence
for dynamic changes in spine morphology and for the impor-
tance of motility at dendritic protrusions in neuronal devel-
opment and synaptic plasticity.
6.2. Dendritic motility in the developing nervous system
Spines were initially described in the mature brain where
they carry the vast majority of excitatory synapses. Recent in
vitro studies, however, revealed that developing neurons also
extend highly dynamic dendritic processes, termed ﬁlopodia
[42]. These structures are usually more elongated than den-
dritic spines and can rapidly appear, extend, and retract (in
tens of minutes) [43]. In addition, they can develop dendritic
growth cones. The movements of these structures have been
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lapse imaging studies. In these experiments, the density of ﬁl-
opodia on mature neurons was found to be much smaller than
on developing cells, leading to the suggestion that ﬁlopodia
establishing a stable synaptic contact with a presynaptic
partner can develop into dendritic spines. However, only 25%
of synapses have been localized on ﬁlopodia in the early
postnatal brain while the rest were found on dendritic shafts
[44]. Filopodia might therefore not be major players in de-
velopmental spinogenesis. Instead, they may have another
speciﬁc role as they have been detected on neurons that later
do not develop spines [45,46]. Now it seems that they are
mainly dendritic precursors, as ﬁlopodia have been shown to
form new dendritic branches in vivo [47]. In the optic tectum of
zebraﬁsh larvae, ﬁlopodia on non-spiny dendritic arbors were
stabilized and formed new dendritic segments only if they had
previously established a stable synaptic contact. These results
support a ‘‘synaptotrophic’’ model for dendritic development,
where synapse formation on ﬁlopodia plays an active role in
shaping the dendritic arbor.
6.3. Dynamic spines in the mature brain
The traditional approach for studying spines of CNS neu-
rons with high resolution is EM. The presence of synapses on
dendritic spines contacted by other neural elements can still
only be conﬁrmed by this technique and exact quantitative
characterization of morphological parameters of spines via 3D
reconstruction also requires serial EM. The EM technique,
however, is not amenable to follow the spontaneous dynamics
of dendritic spines. Thus, the introduction of live confocal
imaging is a crucial technical advance that allows the visuali-
zation of mature neurons in isolated neural systems and the
investigation of the relationship between structure and func-
tion of dendritic spines with high temporal resolution. Rapid
changes in the morphology of dendritic protrusions have been
detected in cultured neural cells [48], neurons in slice cultures
[49], and ganglion cells of the isolated retina [50]. Recently,
further reﬁnement with time-lapse imaging and correlated ul-
trastructural analysis led to the demonstration that motile
spines form synaptic contacts. It was shown in cerebellar slice
cultures that Purkinje cell spines with synapses are able to
move [51]. The degree of spine motility appeared to closely
correlate with the space available for moving spines, suggesting
that spatial constraint imposed by surrounding neural and
glial elements may reduce spine motility. The question of
whether moving Purkinje cell spines detached from their pre-
synaptic partner or just morphed around the intact synaptic
contact still remains to be answered.
More recently, the advent of two-photon in vivo confocal
microscopy led to the demonstration that spines are motile
under certain conditions in the intact living brain [52]. Further
improvement of this imaging technique is, however, needed for
the visualization of synapses on motile spines. Thus, in a re-
cently published elegant study [53] assessing long-term in vivo
spine dynamics in the mouse brain, a combinatorial approach
was employed: the apical dendritic segments of mouse barrel
cortex neurons were ﬁrst visualized in vivo, then identiﬁed
spines were later reconstructed using serial EM. Two of the
four spines which emerged from the reconstructed dendritic
segments during the last day of imaging had clearly identiﬁable
synapses on their head, providing ﬁrm evidence that new
spines can form synapses in the adult brain. Further, results ofthe study support the view that these synapses were newly
formed (as opposed to the possibility of raising pre-existing
shaft synapses by the emerging new spines), suggesting an
active role for dendritic spines in synaptogenesis. Kinetic
properties of spine motility were also measured in these ex-
periments: in the barrel cortex of adult mice 83% of spines were
stable for over a day, 77% of spines were stable over 2–3 days,
60% of spines were stable over at least 8 days, and 50% of
spines were stable over 1 month. These data suggest a re-
markably high turnover of dendritic spines in the adult brain,
with no obvious change in spine density over the dendritic
segments. Accordingly, the mean lifetime of stable spines has
been estimated to be as short as 4 months. The authors also
conﬁrmed a correlation between spine stability and morphol-
ogy, with large mushroom shaped spines being the most stable.
The plasticity of spine dynamics was also demonstrated: the
contralateral whiskers were trimmed in a chessboard pattern to
induce unilateral remodelling of whisker representation in the
barrel cortex. Chessboard deprivation boosted spine turnover
2–3 days later in the corresponding barrel cortex by increasing
the number of transient spines and decreasing the number of
stable spines. Apparently, these two processes counterbalanced
each other resulting in unchanged overall spine density.
Interestingly, another study employing transcranial in vivo
imaging to visualize apical dendrites of pyramidal cells in the
primary visual cortex of mice reported a much lower rate of
spine dynamics [54]. In young animals, only 1% of the visible
dendritic protrusions extended or retracted within 4 days.
Accordingly, 94% of spines remained stable over 3 days, 82%
were stable over 2 weeks, and 73% of spines persisted for over
1 month. Filopodia that represented around 10% of the pro-
trusions in young mice were much more dynamic; 90% of them
extended or retracted within 4 days and only rarely (<1%)
developed into spines. In adults, an even higher level of spine
stability was noticed. More than 99% of dendritic protrusions
were spines and no change in their number or location was
observed in 99% of them within 3 days, in 97% of them over 2
weeks, or in 92% over 2 months. Even when neurons were
repeatedly imaged over 4 months, 80% of the spines remained
stable and the new spines appearing during this time consti-
tuted only 10% of total spine number. The estimated half-life
of dendritic spines in adult mice was over 13 months, implying
that dendritic spines remain unchanged for extended periods
during the lifetime of the animal. Accordingly, the authors
argued that the observed high level of structural stability in the
adult nervous system could serve as a structural basis for long
term storage of memory. The signiﬁcant changes in spine
morphology observed in periods of 3 days and 1 month in
adult mice were, in turn, suggested to be associated with plastic
changes in synaptic eﬃcacy underlying new memory.
The strikingly diﬀerent kinetic properties of cortical spines
described in the above reports could be explained by the in-
herently diﬀerent rates of spine dynamics in various regions of
the cerebral cortex. Though, this hypothesis is not supported
by observations describing similar kinetic parameters for spine
turnover in diverse regions of the monkey brain [55,56]. Re-
markably similar conclusions were drawn, however, in these
two studies regarding the plasticity of axonal and dendritic
branches. Both groups suggested that these neural processes
are highly stable in the adult brain, leaving the role of estab-
lishing and disrupting physical connections between pre- and
postsynaptic partners for the dendritic spines.
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Motility of dendritic spines is regulated by a network of
interacting signalling pathways recognized to involve Rho
GTPases [57,58], protein kinases and PPs, in particular PP1.
These signalling pathways mainly exert their eﬀects by direct-
ing the dynamic reorganization of the actin microﬁlament
system in spines [48], a process intimately linked to synaptic
plasticity [59,60]. As already mentioned before, the action of
PP1 can be both restricted and facilitated by various regula-
tory subunits, which appear to be critical for the regulation of
spine motility. Major regulatory subunits include neurabins
that target the catalytic subunit of PP1 to dendritic spines. In
vertebrates, two neurabin isoforms exhibiting 48% homology
in their amino acid sequences have been identiﬁed: neurabin I
and neurabin II (also named spinophilin). Neurabin I was
isolated as an actin-binding protein that is present in neural
growth cones and dendritic spines [30], while spinophilin was
identiﬁed as a binding partner of PP1 enriched in spine heads
in the hippocampus [13]. Both proteins can be isolated from
the brain in the same PP1 complex [32], in accord with bio-
chemical data suggesting homo- and heterodimerization for
both neurabins.
Structurally, both neurabin I and spinophilin are large
scaﬀolding proteins that carry a series of protein interacting
domains (Fig. 2). Both proteins have an NH2-terminal F-actin
binding domain (BD), a central PP1 binding ‘‘RVXF’’ module,
a PDZ domain, and a COOH-terminal putative ‘‘coiled coil’’
domain. The F-actin BD of spinophilin has been shown to be
necessary and suﬃcient for targeting the protein to dendritic
spines [61]. Also, this region in spinophilin is suﬃcient to
bundle actin ﬁlaments. When phosphorylated by PKA on Ser-
177, spinophilin still binds F-actin with high aﬃnity but with
reduced stoichiometry [62]. In consequence, PKA phosphory-
lation of spinophilin on Ser-177 releases spinophilin from F-
actin. In contrast, activation of Rac1 GTPase can target PP1
to the cytoskeleton by promoting the F-actin binding of
neurabin I.
The COOH terminal ‘‘coiled coil’’ domains in neurabins
can serve to stabilize homo- and heterodimers of neurabin
molecules. Binding of the trans-Golgi network membrane
protein 38 kDa (TNG38) to this region is stronger in neurabin
dimers, providing an additional way for stabilizing the asso-
ciation of neurabins. TNG38, an integral membrane protein,
also directly attaches TNG38-containing membranes to the
actin ﬁlament network. Besides F-actin binding, spinophilin
can also target PP1 to several G-protein coupled neuro-
transmitter receptors by binding to their third intracellular
loop. These receptors include the a2A-, a2B-, and a2C-adren-Fig. 2. Structure of a spinophilin/neurabin I heterodimer with associ-
ated proteins. PP1 and p70S6K can only bind to neurabins in a mu-
tually exclusive manner (see text).ergic and D2 dopaminergic receptors [21], as mentioned ear-
lier. Finally, spinophilin has also been reported to bind
ryanodine receptors and proposed to mediate the association
of PP1 with them.
Neurabins are phosphorylated by PKA at Ser-461 and this
event leads to the dissociation of PP1 from neurabin I. PP1
binds neurabins via the ‘‘RVXF’’ module and each of its cat-
alytic subunits has a diﬀerent aﬃnity for that module
(PP1c>PP1a>PP1b). The binding site of PP1 on neurabins
overlaps with the binding site of the p70S6K, a mitogen acti-
vated protein kinase. Accordingly, the binding of the PP1 and
p70S6K to neurabins is mutually exclusive. It has been shown,
however, that neurabin I prefers to bind PP1 as opposed to
p70S6K implying that the dissociation of PP1 from neurabin I
is a pre-requisite for the binding of the kinase. It is worth
noting that p70S6K plays an antagonistic role in the regulation
of cellular morphology as compared to PP1. Active p70S6K
induces the assembly of stress ﬁbres while, in contrast,
neurabin associated PP1 can initiate their disassembly and the
formation of extended ﬁlopodia [63].
The signiﬁcance of neurabins in shaping neural processes
has been veriﬁed by eliminating neurabins from cells by ge-
netic or molecular manipulations. Spinophilin knockout mice
totally lacking spinophilin display a reduced brain size and a
higher number of dendritic spines, accompanied by altered
NMDA and AMPA receptor functions, reduced LTD, and a
higher resistance to kainite-induced seizures and apoptosis
[33]. Thus, it seems that hampered anchoring of PP1 in den-
dritic spines profoundly aﬀects neural development, mor-
phology and functions. Intriguingly, neurabin I antisense
oligonucleotides hindered the formation of neurites in hippo-
campal cells [30], in contrast to the higher spine density ob-
served in spinophilin knockout mice. Clearly, further
investigations are needed to resolve this discrepancy and
clarify the role of PP1 targeting neurabins in the structural
plasticity of neural processes.7. Learning, memory and forgetting
Several recent studies have investigated the role of PP1 in
learning and memory by taking advantage of transgenic
methodologies in mice. The genetic inhibition of PP1 by tem-
porally controlled expression of the endogenous PP1 inhibitor
I1 in forebrain neurons demonstrated a connection between
repetitive learning and PP1 [64]. Repetitive learning is required
for the formation and storage of accurate and long-lasting
memory, with repetition being most eﬀective when widely
distributed over time rather than closely spaced or massed.
When PP1 was genetically inhibited in both the hippocampus
and cortical regions during learning, shorter intervals between
training episodes were necessary for optimal performance in
novel object recognition and Morris water maze tests. The
observed learning enhancement correlated with increased
phosphorylation of several synaptic and nuclear targets of PP1
including GluR1, CaMKII, and cyclic AMP-dependent re-
sponse element binding (CREB) protein. For GluR1, phos-
phorylation levels of both Ser-845 and Ser-831 (unpublished)
sites were found to be higher due to PP1 inhibition possibly
reﬂecting an increase in the basal level of glutamatergic
transmission. This shift in the overall balance of glutamate
receptor phosphorylation towards a more excited state may
R.P. Munton et al. / FEBS Letters 567 (2004) 121–128 127induce changes in the processes leading to LTD. Inhibition of
PP1 additionally prolonged memory when induced only after
learning, suggesting that PP1 also promotes forgetting. This
property may account for ageing-related cognitive decay, as
old mutant animals, in which PP1 was inhibited during and
after learning, had preserved memory. These ﬁndings em-
phasize the physiological importance of PP1 as a suppressor of
learning and memory, and as a potential mediator of cognitive
decline during ageing. Such a PP1-mediated constraint upon
memory could provide a molecular mechanism to erase erro-
neous memories. Continued activation of neural pathways is
thought to maintain memories, whereas disuse will lead to
active erosion and prevent the aggregation of superﬂuous
neural activity.
Additional studies employing genetic or pharmacological
approaches demonstrated a relationship between PP1 and
learning and memory. Mice lacking two of the endogenous
inhibitors of PP1, I1 and DARPP-32, were found to exhibit
reduced cocaine place preference test performance; a
behavioural test which measures the ability of the animal to
associate a speciﬁc location with a rewarding drug [65]. These
results support a role of PP1 in the mediation of changes in
neuronal signalling that occurs following activation of the
dopaminergic system. Pharmacological inhibition of PP1 in
vivo also induces deﬁcits in memory retention. Bennett et al.
[66,67] found that the inhibition of PP1 or PP2A in chick brain
by various concentrations of okadaic acid produced tempo-
rally speciﬁc deﬁcits in memory retention. This suggested that
diﬀerent phosphatase enzymes may contribute to diﬀerent
stages of the enzymatic cascade believed to underlie memory
formation.
The role of PP1 in memory and learning could also have
relevance to clinical conditions. In addition to a possible in-
volvement in age-related cognitive decline [64], a link between
PP1 and impairment of spatial memory in Alzheimer’s disease
has been suggested. Hyperphosphorylation of Tau, a protein
that sequesters PP1 to microtubules, leads to the formation of
paired helical ﬁlament/neuroﬁbrillary tangles, a hallmark for
Alzheimer’s pathology. It was found that rats injected with the
PP1 and PP2A inhibitor, calyculin A, develop deﬁcits in spatial
memory retention in the Morris water maze test [68]. These
results could pave the way for future research into the speciﬁc
pathways of PP1 and lead to the development of treatments for
memory and learning disorders in humans.8. Conclusion
It is becoming increasingly clear that the actions of phos-
phatases regulate synaptic transmission in a highly speciﬁc and
regulated manner. PP1 regulation can be activity-dependent
and involve cross-talk between diﬀerent signalling pathways
from the level of molecular interactions to co-operation be-
tween diﬀerent neurotransmitter systems. Additionally, an
important role has been implicated for PP1 and interacting
proteins in structural plasticity. This review explored only a
few of the known PP1 targets at synapses and undoubtedly
there are many more to be discovered. Delineating the roles of
speciﬁc phosphatases in speciﬁc brain regions and subcellular
locations, and identifying novel target substrates provide
challenges for the future. The current advances in the analysis
of protein networks in the post-genomic era look promisingand novel proteomic methodologies could be of beneﬁt to this
ﬁeld. Additionally, continuing improvements to transgenic
techniques, will aid generation of animals which express or
knock out proteins with increased spatial and temporal accu-
racy. This could help the analysis of speciﬁc pathways in
speciﬁc brain regions, as currently studies in memory and
learning are diﬃcult due to the heterogeneity and complexity
of signalling in the brain at all levels.
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